Ribonuclease R: A Topology Test for circRNA

Introduction: from enrichment reagent to causal assay

Circular RNA research often begins with a simple observation: a transcript signal remains after digestion with Ribonuclease R. Because circular RNAs are covalently closed, they lack the exposed 5′ and 3′ ends that many exonucleases require. Linear RNA, by contrast, is generally more accessible to a processive 3′-to-5′ exonuclease. This biochemical difference makes RNase R a valuable perturbation for testing RNA topology.

However, RNase R resistance is not synonymous with circularity. Strong secondary structure can protect a linear transcript, while damaged, nicked, or unusually accessible circular RNA may be lost during treatment. The most defensible use of this enzyme is therefore not as a stand-alone discovery tool, but as one layer in an orthogonal evidence chain that combines topology, junction-specific amplification, localization, and functional perturbation.

This distinction is particularly important in inflammation biology. The recent study of pulpitis by Lai and colleagues identified a circ_0042103/TAF15/NER axis associated with DNA damage and inflammatory signaling in human dental pulp stem cells. The study provides a compelling biological context for circular RNA investigation, while also clarifying why biochemical enrichment alone cannot establish mechanism. The practical question is not merely whether a transcript survives digestion, but whether its topology-resolved signal supports a biologically coherent model.

How RNase R discriminates RNA substrates

Processivity, free ends, and topology

Ribonuclease R is a highly processive exoribonuclease that moves from a free RNA terminus toward the molecule’s interior. Linear RNA molecules therefore present an entry point for progressive degradation. A covalently closed circular RNA does not provide the same initiating end, allowing many circRNA molecules to persist under suitable reaction conditions. The Ribonuclease R (RNase R) (20 U/μL) preparation is supplied with a 10× RNase R Reaction Buffer intended to support enzymatic activity.

Resistance is governed by more than topology. Stem-loops, duplex regions, bound proteins, chemical modifications, and transcript length can alter enzyme access or processivity. Conversely, a circular RNA containing a nick is no longer topologically closed and may become vulnerable to degradation. These variables explain why RNase R treatment is best interpreted as a topology-sensitive challenge rather than a binary circular-versus-linear detector.

What the surviving fraction means

After digestion, the remaining RNA population is enriched for molecules that resist the particular combination of topology, structure, accessibility, and reaction conditions used in the experiment. A higher post-treatment signal for a candidate circRNA is supportive evidence, especially when divergent primers amplify the predicted back-splice junction. It is not, by itself, proof that the transcript is circular or that it performs a specific cellular function.

This principle makes the enzyme useful in RNA structure analysis and RNA stability studies, but it also imposes an interpretive obligation: untreated and treated aliquots should be compared at matched input, and the result should be reported as relative resistance rather than absolute circularity.

Reference insight: what the pulpitis study changes

The most meaningful innovation in the pulpitis study is its integration of disease-level and mechanism-level evidence. Lai et al. combined microarray analysis of inflammatory pulp with single-cell RNA sequencing of derived stem cells, then connected the observed DNA damage response to a specific circRNA candidate. Functional experiments showed that circ_0042103 increased LPS-associated DNA damage and inflammatory effects, whereas knockdown produced the opposite trend. The authors further used RNA FISH, RNA pulldown, nuclear–cytoplasmic fractionation, and targeted depletion to support an interaction with TAF15 and altered levels of the nucleotide excision repair-associated proteins ERCC1 and PCNA. These findings are described in the open-access pulpitis study by Lai and colleagues.

For assay design, this is more important than the disease model alone. The work separates three questions that are often conflated:

• Is the RNA species structurally consistent with a circular transcript? RNase R resistance and divergent-junction amplification can address this question.
• Where is the transcript located and what does it bind? FISH, fractionation, and pulldown provide evidence that digestion cannot supply.
• Does changing the transcript alter the phenotype? Knockdown or other perturbation is required to connect the RNA to DNA damage and inflammation.

Thus, the study’s practical lesson is to use RNase R upstream of mechanistic assays as a quality-control and identity step, not as a substitute for them. A surviving signal for circ_0042103 would strengthen the molecular assignment; it would not independently prove TAF15 binding, NER regulation, or causality in pulpitis.

A topology-aware assay strategy for inflammation-linked circRNA

Design the comparison before treating the RNA

Begin with matched aliquots from the same RNA preparation. Retain an untreated control and expose a parallel aliquot to RNase R under the conditions recommended for the enzyme and the downstream assay. This paired design distinguishes true treatment-associated resistance from differences in extraction, loading, reverse transcription, or amplification efficiency.

For quantitative PCR, use divergent primers that span the predicted back-splice junction to monitor the circular species. Include convergent primers directed toward the linear transcript when possible. The resulting pattern is more informative than either amplicon alone: enrichment of the divergent signal after digestion supports circularity, whereas persistence of a convergent signal may indicate incomplete digestion, a protected linear isoform, or primer cross-reactivity.

Use orthogonal controls to prevent overinterpretation

RNase R-resistant candidates should be tested with a second assay that addresses a different property. Sanger sequencing of the divergent amplicon can verify the junction sequence; FISH can evaluate intracellular distribution; and loss-of-function experiments can examine whether the candidate affects the proposed inflammatory or DNA damage phenotype. A no-reverse-transcription control remains useful for excluding DNA-derived amplification, particularly when genomic loci or plasmid constructs could contribute background.

For sequencing, RNase R can reduce linear RNA background before library construction, but depletion changes library composition and may favor highly structured or unusually stable species. An untreated companion library is therefore valuable when the objective includes abundance estimation, isoform comparison, or discovery of unexpected RNA classes. Enrichment and quantification should be treated as different analytical goals.

Protocol Parameters

• Enzyme identity: use RNase R as a processive 3′-to-5′ exoribonuclease for selective linear RNA digestion; interpret survival as topology- and structure-dependent resistance.
• Enzyme concentration: the K3061 preparation is supplied at 20 U/μL; calculate the reaction input from the activity requirement of the validated application rather than transferring a volume between assays without optimization. See the product information for Ribonuclease R.
• Reaction buffer: use the supplied 10× RNase R Reaction Buffer and follow the current manufacturer instructions for reaction assembly, compatibility, and inactivation.
• Matched controls: process untreated and RNase R-treated aliquots in parallel, then normalize downstream measurements to input RNA and assay-specific recovery.
• Optimization: vary enzyme exposure and input amount empirically when working with highly structured linear RNA, long transcripts, degraded samples, or low-abundance circRNAs; these are workflow recommendations rather than parameters established by the pulpitis study.
• Storage and transport: store the enzyme at −20°C. The product information reports an approximate two-year shelf life under recommended storage and dry-ice shipment for transit stability.

How this approach differs from routine enrichment workflows

A conventional circular RNA enrichment workflow treats RNase R as the central cleanup step. The Ribonuclease R circular RNA enrichment workflow is useful for understanding setup, circRNA validation, and troubleshooting. The present strategy builds on that foundation but changes the endpoint: instead of asking only whether background was reduced, it asks whether the resistance profile is consistent with the proposed molecular mechanism and with independent measurements.

Similarly, the article on RNase R and high-fidelity circular RNA research emphasizes advanced enrichment and structure–function applications. This article takes a narrower but deeper perspective by treating digestion as a perturbational experiment. The critical output is not simply a cleaner sample; it is a comparison between untreated and challenged states that can be integrated with localization and functional data.

Finally, the inflammation-focused discussion in Ribonuclease R in circular RNA discovery connects the enzyme to disease biology. The approach here complements that translational framing by concentrating on evidentiary boundaries: RNase R can support transcript identity in an inflammatory model, but it cannot alone demonstrate a circRNA–protein interaction or establish a downstream RNA processing pathway.

Applications beyond simple circRNA enrichment

RNA structure analysis and stability studies

Comparing digestion resistance across transcript variants can reveal whether sequence changes alter accessibility or higher-order structure. This is particularly useful when a mutation, binding partner, or cellular condition is suspected to remodel an RNA. Such experiments should be described as comparative structure or stability studies, because RNase R measures susceptibility under an in vitro reaction environment rather than physiological half-life.

RNA-sequencing library preparation

Selective depletion of linear RNA can increase the relative representation of circular species in sequencing libraries. Yet the resulting dataset is an enriched population, not a direct transcriptome census. Researchers should preserve a pre-enrichment aliquot where possible, document the treatment as part of library metadata, and validate important candidates by junction-spanning methods.

Connecting identity to an RNA processing pathway

Once a resistant transcript is verified as circular, it can be placed into a broader RNA processing pathway that includes back-splicing, nuclear export, localization, protein binding, and turnover. RNase R contributes only to the identity and enrichment layer. This modular view prevents a common error in which biochemical persistence is presented as evidence for a complete regulatory mechanism.

Limitations and decision points

RNase R can underrepresent circular RNAs that are nicked, heavily structured in an enzyme-accessible configuration, or associated with contaminants that affect digestion. It can also leave behind linear RNAs protected by secondary structure or ribonucleoprotein complexes. Degraded input introduces an additional problem because fragments may behave differently from intact transcripts and complicate normalization.

Consequently, the strongest claim supported by a single treatment is usually that a measured RNA signal is relatively resistant under defined conditions. Claims of circular topology should add junction confirmation; claims of localization should add imaging or fractionation; and claims of function should add perturbation and rescue logic. In the pulpitis setting, this layered evidence is essential because the proposed link between circ_0042103, TAF15, ERCC1/PCNA, DNA damage, and inflammation spans several biological levels.

Conclusion

Ribonuclease R is best understood as a topology-sensitive experimental challenge. The RNase R (20 U/μL) formulation from APExBIO, supplied with reaction buffer and intended for −20°C storage, supports reproducible implementation when paired samples and orthogonal controls are built into the design. For inflammation-associated circRNA research, the key advance is conceptual: use linear RNA digestion to test molecular identity, then use independent assays to establish localization, interaction, pathway involvement, and phenotype. This approach turns a routine enrichment step into a more rigorous framework for RNA structure analysis, circular RNA enrichment, and mechanism-driven RNA biology.